Policy

Genomic data can have a significant effect on other areas of society. Insurance premiums, familial impact, identification. As we enter the genomic era, policy will need to reflect these new considerations.

MP’s Vote to Remain in EMA Post-Brexit

MPs vote 305-301 that the UK should negotiate to remain part of the European Medicines Agency following Brexit, sending “a clear message that patients and public health should be a top priority”.

Data From 1 Million

The All of Us Research Program is a key element of the Precision Medicine Initiative. Two years on, we take a look at what they have achieved, and how they plan on integrating their research into the U.S. healthcare system over the next ten years.